反复流产的临床试验
总计64463个结果
-
Baptist Health, LouisvilleUniversity of Kentucky; Drexel University; Innovative Institute; Foshan Chancheng Hospital尚未招聘
-
Merck Sharp & Dohme LLC终止
-
The University of Hong Kong招聘中
-
Assistance Publique Hopitaux De Marseille未知
-
Northwestern UniversityNational Cancer Institute (NCI); BrainUp Inc尚未招聘
-
Roswell Park Cancer InstituteAstraZeneca主动,不招人BRCA1基因突变 | BRCA2基因突变 | 复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢浆液性腺癌美国
-
Medical University of Vienna招聘中髓母细胞瘤复发 | 复发性室管膜瘤 | ATRT 周期性奥地利, 瑞典, 法国, 西班牙, 美国, 捷克语, 丹麦, 挪威
-
Washington University School of MedicineChildren's Discovery Institute尚未招聘
-
University of South AlabamaExelixis终止
-
Daiichi SankyoMerck Sharp & Dohme LLC招聘中
-
Royal Marsden NHS Foundation Trust招聘中
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex Therapeutics招聘中复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 复发性子宫内膜浆液性腺癌 | 卵巢透明细胞腺癌 | 复发性铂耐药卵巢癌 | 铂敏感性卵巢癌 | 复发性输卵管子宫内膜样腺癌 | 复发性卵巢透明细胞腺癌 | 复发性卵巢子宫内膜样腺癌 | 复发性原发性腹膜透明细胞腺癌 | 复发性原发性腹膜子宫内膜样腺癌 | 复发性卵巢浆液性腺癌 | 复发性原发性腹膜浆液性腺癌 | 复发性输卵管浆液性腺癌美国
-
Royal Marsden NHS Foundation TrustOracle Cancer Trust; Biomedical Research Centre招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘PD-L1阳性(CPS≥1)的复发或转移性宫颈癌
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
Kevelt ASPharmasyntez未知
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.招聘中
-
UBP Greater China (Shanghai) Co., Ltd尚未招聘
-
Gary Archer Ph.D.National Cancer Institute (NCI); Duke Cancer Institute终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
University of OklahomaTesaro, Inc.招聘中
-
Corcept Therapeutics主动,不招人复发性输卵管癌 | 复发性原发性腹膜癌 | 复发性卵巢癌美国, 比利时, 加拿大, 意大利, 西班牙
-
Westlake UniversityBeijing Obstetrics and Gynecology Hospital完全的
-
Haukeland University HospitalUniversity Hospital of North Norway; St. Olavs Hospital尚未招聘
-
Centre Leon BerardNational Cancer Institute, France; Fondation ARC完全的